IRENE DAVIS
Profile
Related Companies
Titles
Company Name
Related People
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
MANUFACTURING
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
$25,000,001 - $100,000,000
Equity
2023-09-15
D
MANUFACTURING
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
$25,000,001 - $100,000,000
Equity
2023-09-15

